| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Humacyte, Inc. (HUMA) has 4 insiders with recent SEC Form 4 filings, including 6 buys and 8 sells. HUMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| Other | 318.6K | $294.5K | - | |
| CFO | 313.1K | $289.4K | - | |
| CEO | 311.1K | $287.6K | - | |
| Dir | 311.1K | $287.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| May 17, 2022 | Sander Dale A.58 | CFO And Chief Corp. Deve. Off. | Buy | 2,000 | $4.53 | $9,060.00 | New | +1.1% | -12.5% | |
| Dec 16, 2021 | Niklason Laura E65 | President, CEO And Director | Sell | 300,000 | $9.10 | $2,729,332.26 | -10.4% | -31.6% | -71.4% | |
| Dec 16, 2021 | Dougan Brady W64 | Director, 10% Owner | Sell | 300,000 | $9.10 | $2,729,332.26 | -10.4% | -31.6% | -71.4% | |
| Nov 22, 2021 | Constantino Michael T. | Director | Buy | 2,500 | $10.79 | $26,985.76 | +1,250% | -51.5% | -69.2% | |
| Aug 26, 2021 | Ayabudge LLC | 10% Owner | Buy | 1,522,500 | $10.00 | $15,225,000.00 | +8.0% | -4.0% | -61.8% | |
| Aug 26, 2021 | Niklason Laura E65 | President, CEO And Director | Buy | 1,522,500 | $10.00 | $15,225,000.00 | +8.0% | -4.0% | -61.8% | |
| Aug 26, 2021 | Dougan Brady W64 | Director, 10% Owner | Buy | 1,522,500 | $10.00 | $15,225,000.00 | +8.0% | -4.0% | -61.8% |